Tivity Health (NASDAQ:TVTY – Get Rating) will be releasing its earnings data after the market closes on Thursday, May 5th. Analysts expect Tivity Health to post earnings of $0.42 per share for the quarter. Tivity Health has set its FY 2022 guidance at $1.750-$1.840 EPS and its FY22 guidance at $1.75-1.84 EPS.
Tivity Health (NASDAQ:TVTY – Get Rating) last posted its earnings results on Thursday, February 24th. The company reported $0.30 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.38 by ($0.08). Tivity Health had a return on equity of 99.51% and a net margin of 21.80%. The company had revenue of $126.80 million during the quarter, compared to analysts’ expectations of $126.57 million. During the same period in the prior year, the business posted $0.38 earnings per share. The company’s revenue for the quarter was up 26.0% on a year-over-year basis. On average, analysts expect Tivity Health to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
NASDAQ:TVTY opened at $32.05 on Thursday. The company has a 50-day moving average price of $30.25 and a 200-day moving average price of $27.14. Tivity Health has a 12 month low of $21.25 and a 12 month high of $32.89. The company has a current ratio of 2.24, a quick ratio of 2.24 and a debt-to-equity ratio of 3.23. The stock has a market cap of $1.60 billion, a price-to-earnings ratio of 15.41, a P/E/G ratio of 1.79 and a beta of 2.30.
Several research firms have recently commented on TVTY. Zacks Investment Research cut shares of Tivity Health from a “hold” rating to a “sell” rating in a research report on Tuesday, March 1st. Barrington Research cut shares of Tivity Health from an “outperform” rating to a “market perform” rating in a research report on Tuesday, April 5th. Truist Financial lifted their price target on shares of Tivity Health from $28.00 to $30.00 in a research report on Wednesday, January 5th. StockNews.com started coverage on shares of Tivity Health in a research report on Thursday, March 31st. They set a “hold” rating for the company. Finally, William Blair reissued a “market perform” rating on shares of Tivity Health in a research report on Thursday, February 24th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $30.67.
Tivity Health Company Profile (Get Rating)
Tivity Health, Inc provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine.
- Get a free copy of the StockNews.com research report on Tivity Health (TVTY)
- Automatic Data Processing Is Ready To Scale New Heights
- Carl Icahn Buys More Xerox
- Xerox Holdings Stock is a Value Play
- The Kraft Heinz Turnaround Story Gains Momentum
- Microsoft (NASDAQ: MSFT) Saves The Day, For Now
Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.